Latest News & Updates
Breaking News
29 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Cloudbreak Pharma Reports Successful End-of-Phase 2 FDA Meeting For CBT-004, Paving Path For Phase 3 Trials In Pinguecula Treatment
Cloudbreak advances CBT-004 toward Phase 3 after a positive FDA End-of-Phase 2 meeting for pinguecula treatment.
Simantini Singh Deo
CytoDyn Announces Funding And Start Of Expanded Access Program For Advanced TNBC Patients Ineligible For Clinical Trials, FDA-Guided Leronlimab Access To Begin March 2026
CytoDyn expands compassionate access to leronlimab for TNBC patients through a newly funded Expanded Access Program.
Simantini Singh Deo
20260129115235.jpg)
Halo Pharma Becomes Independent CDMO After Noramco Sells API Business To Siegfried, Focusing Fully On Drug Product Development And Manufacturing
Halo Pharma will operate independently as a drug product CDMO, expanding sterile manufacturing alongside oral and semi-solid capabilities.
Simantini Singh Deo
Lexeo Therapeutics Strengthens Leadership With Narinder Bhalla As CMO, José Manuel Otero As COO, And Key Appointments To Advance Cardiovascular Genetic Therapies
Lexeo names new medical and development leaders to advance late-stage cardiovascular genetic medicine and RNA-based therapies.
Simantini Singh Deo
